What topical antifungal medication and dosing regimen should be used to treat a cutaneous fungal infection?

Topical Antifungal Treatment Recommendations

For cutaneous fungal infections (tinea corporis, tinea cruris, tinea pedis), use topical terbinafine cream 1% once daily for 1-2 weeks or topical naftifine 1-2% once daily for 1-2 weeks as first-line therapy. These allylamine agents are fungicidal and achieve higher cure rates with shorter treatment durations compared to azole alternatives 1, 2.

Treatment Selection by Infection Type

Dermatophyte Infections (Tinea Corporis, Cruris, Pedis)

Allylamines are superior to azoles for dermatophyte infections. The evidence strongly favors fungicidal agents over fungistatic ones:

• Terbinafine 1% cream: Apply once daily for 1-2 weeks

  • Pooled data shows RR of treatment failure 0.33 (95% CI 0.24-0.44) vs placebo, with NNT of 3 1
  • Meta-analysis demonstrates allylamines are more effective than azoles (RR 0.63,95% CI 0.42-0.94) 2

• Naftifine 1-2% cream: Apply once daily for 1-2 weeks

  • Mycological cure RR 2.38 (95% CI 1.80-3.14) vs placebo, NNT 3 1
  • Clinical cure RR 2.42 (95% CI 1.41-4.16) vs placebo 1
  • The 2% formulation provides a therapeutic reservoir effect after treatment completion 3

• Butenafine cream (benzylamine): Alternative fungicidal option with similar efficacy (RR 0.33,95% CI 0.24-0.45) 1

Candida (Yeast) Infections

For cutaneous candidiasis, use topical azoles rather than allylamines. Azoles have superior activity against yeasts 4, 3:

• Clotrimazole 1% cream: Apply twice daily for 2-4 weeks

  • Mycological cure RR 2.87 (95% CI 2.28-3.62) vs placebo, NNT 2 1

• Ketoconazole 2% cream: Apply once or twice daily for 2-4 weeks

• Miconazole cream: Apply twice daily for 2-4 weeks

Why Allylamines Over Azoles for Dermatophytes

The critical distinction is mechanism of action 4:

• Allylamines (terbinafine, naftifine, butenafine): Fungicidal—actually kill organisms
• Azoles (clotrimazole, ketoconazole, miconazole): Fungistatic—only inhibit growth, relying on epidermal turnover to shed fungi

This matters clinically because patients typically stop treatment when skin appears healed (usually after 1 week). With fungistatic agents, premature discontinuation leads to higher recurrence rates since organisms remain viable 4. Fungicidal agents achieve cure with treatment as short as 1 week 4, 3.

Treatment Duration and Application

• Tinea corporis/cruris: 1-2 weeks of once-daily application typically sufficient
• Tinea pedis: May require 2-4 weeks, especially for moccasin-type presentation
• Continue treatment for at least 1 week after clinical clearing to prevent relapse 5

Important Caveats

When Topical Therapy Is Insufficient

Topical therapy alone is not appropriate for 6, 5:

• Tinea capitis (requires oral therapy)
• Onychomycosis (nail infections—poor penetration through nail plate) 4, 2
• Extensive disease covering large body surface areas
• Failed topical treatment
• Immunocompromised patients

Avoid Topical Steroid-Antifungal Combinations

Although combination products show slightly higher clinical cure rates at end of treatment (RR 0.67,95% CI 0.53-0.84), they show no difference in mycological cure 1. Current clinical guidelines do not recommend these combinations due to concerns about steroid-related adverse effects and masking of infection 1.

Adjunctive Measures

For tinea pedis, consider antifungal shampoos (ketoconazole 2%, selenium sulfide 1%) to reduce spore transmission, though these are insufficient as monotherapy 6.

Adverse Effects

All topical antifungals demonstrate excellent safety profiles with minimal adverse effects—primarily mild irritation and burning that occur infrequently and show no significant difference from placebo 1, 2.